farglitazar peroxisome proliferatoractivated receptor agonist formerly development glaxosmithkline never marketed progressed phase ii clinical trials treatment hepatic fibrosis failed show reaching phase iii type diabetes development drug article relating gastrointestinal system stub help wikipedia expanding httpsenwikipediaorgwikifarglitazar